Hutch News

Hutch News

Stories tagged 'vaccine'

Insights from infants could inform HIV vaccine design

Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV

Nov. 27, 2017 | By Sabrina Richards / Fred Hutch News Service

Infant immune responses to HIV could provide clues to help build protective or therapeutic HIV vaccines.

View story >


Teacher, mom — and living proof of principle

Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.

Sept. 8, 2017 | By Susan Keown / Fred Hutch News Service

When Tiffany's advanced cancer kept coming back, she decided to become the first person in the world to receive a still-experimental new immunotherapy.

View story >


Using a virus to teach the immune system to kill cancer

‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma

June 2, 2017 | By Susan Keown / Fred Hutch News Service

This cancer vaccine uses a virus to teach sarcoma patients’ immune systems to kill tumor cells. It was tested in an early-stage clinical trial.

View story >


Nearly half of U.S. men actively infected with HPV, study finds

HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated

Jan. 19, 2017 | By Rachel Tompa / Fred Hutch News Service

HPV-linked cancers on the rise in men, but nearly nine in 10 vaccine-eligible men are unvaccinated, new research shows.

View story >


Collaborating with China to help kids

New Fred Hutch study looks at whether persistent organic pollutants can undercut vaccines

July 7, 2016 | By Diane Mapes / Fred Hutch News Service

Could persistent organic pollutants interfere with the effectiveness of vaccines? A new five-year collaboration between Fred Hutch and the Chinese Centers for Disease Control and Prevention is about to find out.

View story >


6 questions in cancer immunotherapy

From cancer vaccines to engineered T cells, experts weigh in on the big unknowns

March 18, 2016 | by Susan Keown / Fred Hutch News Service

Fred Hutch immunotherapy experts share their perspectives on a few of the big questions in cancer immunotherapy research — and the steps that they and their colleagues are taking to answer them as quickly as they can.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.